Author:
Khan Naila,Khan Khushbukhat,Badshah Yasmin,Trembley Janeen H.,Ashraf Naeem Mahmood,Shabbir Maria,Danish Lubna,Afsar Tayyaba,Almajwal Ali,Justin Saira,Hasan Zafarul,Razak Suhail
Abstract
AbstractHepatocellular carcinoma is a leading cause of cancer-related deaths due to its complexity in diagnosis, chemo-resistance, and aggressive nature. Identifying pathogenic single nucleotide polymorphism (SNP) in protein kinase C iota (PKCι) can be a potential biomarker in the prognosis and treatment of HCC. This study investigated the association between a SNP in PRKCI and the Pakistani population's hepatocellular carcinoma (HCC) risk. Obtained samples were first evaluated for ALT measurements and viral load quantification through reverse transcriptase-PCR. The PKCι nsSNP rs1199520604 was evaluated computationally by multiple consensus bioinformatics tools for predicting its potential deleterious effects. Its association with hepatitis C virus- (HCV) mediated HCC was then investigated through ARMS-PCR (Amplification Refractory Mutation System Polymerase Chain Reaction). SNP analysis of rs1199520604 was performed in 100 cases and 100 controls. Variant rs1199520604’s homozygous T genotype is a risk factor allele for the HCV-induced HCC (odds ratio: 4.13, relative risk: 2.01, P-value < 0.0001). The heterozygous genotype is determined to protect HCV patients from HCC development (P < 0.001). The study highlighted the disease association of variant rs1199520604 with HCV-induced HCC in the Pakistani populations. This variant, after further validation through high-throughput investigation on a larger cohort, has the potential to be translated at the clinical level.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Srivatanakul, P., Sriplung, H. & Deerasamee, S. J. A. P. J. O. C. P. Epidemiology of liver cancer: An overview. Asian Pac. J. Cancer Prevent. 5, 118–125 (2004).
2. Ferlay, J. et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur. J. Cancer 103, 356–387 (2018).
3. Kulik, L. & El-Serag, H. B. J. G. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156, 477-491. E471 (2019).
4. Vescovo, T. et al. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clin. Microbiol. Infect. 22, 853–861 (2016).
5. Chen, Z. et al. ACYP2 polymorphisms are associated with the risk of liver cancer in a Han Chinese population. Oncotarget 8, 67723–67731. https://doi.org/10.18632/oncotarget.18574 (2017).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献